Sana Biotechnology (NASDAQ:SANA – Get Free Report) and Passage Bio (NASDAQ:PASG – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings. Volatility & Risk Sana Biotechnology has a […]
Passage Bio (NASDAQ:PASG) Given New $13 00 Price Target at Canaccord Genuity Group wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
PASG Stock Earnings: Passage Bio Beats EPS for Q1 2024 biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.
Passage Bio (NASDAQ:PASG) Trading 0 7% Higher dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
PHILADELPHIA, April 22, 2024 Passage Bio, Inc. , a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced that.